F/M Emerald Life Sciences Innovation ETF (LFSC)

Assets	$60.81M
Expense Ratio	0.54%
PE Ratio	n/a
Shares Out	2.31M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Ratio	n/a
1-Year Return	n/a

Volume	9,754
Open	27.22
Previous Close	27.12
Day's Range	27.22 - 27.32
52-Week Low	18.78
52-Week High	27.76
Beta	n/a
Holdings	37
Inception Date	Oct 31, 2024

About LFSC

Fund Home Page

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: LFSC
• ETF Provider: F/m Investments

Top 10 Holdings

50.79% of assets

Name	Symbol	Weight
RadNet, Inc.	RDNT	6.61%
LivaNova PLC	LIVN	6.54%
TransMedics Group, Inc.	TMDX	5.89%
Travere Therapeutics, Inc.	TVTX	5.59%
Soleno Therapeutics, Inc.	SLNO	5.57%
Collegium Pharmaceutical, Inc.	COLL	4.92%
Merit Medical Systems, Inc.	MMSI	3.99%
KalVista Pharmaceuticals, Inc.	KALV	3.96%
BridgeBio Pharma, Inc.	BBIO	3.93%
Guardant Health, Inc.	GH	3.78%